Cross-Sector entity

E-MOTIVE

Technology
8

medical-devices is the sole category represented across all 1 tracked stories. E-MOTIVE is most often covered alongside Arri Coomarasamy, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. E-MOTIVE appears in 1 tracked Cross-Sector story from June 30, 2026.

1 verified story tracked

Last mentioned: Jun 30, 2026

Entity pulse

Recent coverage · E-MOTIVE

1 story
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about E-MOTIVE

medical-devices is the sole category represented across all 1 tracked stories. E-MOTIVE is most often covered alongside Arri Coomarasamy, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. E-MOTIVE appears in 1 tracked Cross-Sector story from June 30, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering E-MOTIVE. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Lancet Series on Postpartum Haemorrhage Published

    The Lancet releases a three-part series consolidating evidence on PPH, the E-MOTIVE strategy, and implementation guidance, with a special emphasis on high-burden countries like India.

  2. E-MOTIVE Trial Published

    A large cluster-randomized trial across low- and middle-income countries demonstrates that objective blood-loss measurement with a calibrated drape plus a bundled treatment package significantly reduces PPH-related severe morbidity and mortality.

Stories mentioning E-MOTIVE 1

Healthcare medical devices Strongly positive 8

Simple Drape Bundle Could Cut 38% of Maternal PPH Deaths: Lancet Series

The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.

2 sources

Source: Kirti Pandey (in) · Kirti Pandey (in)